Targeting cholesterol homeostasis in lung diseases

Area of Science:

• Pulmonary medicine
• Cell biology
• Immunology

Background:

• Macrophages are essential for organ function and implicated in various diseases.
• Pulmonary alveolar proteinosis (PAP) is a rare lung disorder characterized by surfactant accumulation.
• Granulocyte/macrophage-colony stimulating factor (GM-CSF) signaling plays a role in maintaining lung homeostasis.

Purpose of the Study:

• To elucidate the mechanisms of GM-CSF in surfactant homeostasis.
• To understand how GM-CSF disruption leads to PAP.
• To evaluate cholesterol-targeted therapies for PAP.

Main Methods:

• Analysis of lipid composition in alveolar macrophages and lung surfactant.
• Assessment of macrophage-mediated surfactant clearance kinetics and dynamics.
• In vitro and in vivo evaluation of cholesterol-targeted pharmacotherapy in PAP models.

Main Results:

• GM-CSF signaling deficiency in macrophages leads to accumulation of cholesterol ester-rich lipid droplets.
• Surfactant from GM-CSF deficient macrophages shows an increased cholesterol proportion.
• GM-CSF regulates macrophage cholesterol clearance in a dose-dependent and reversible manner, without affecting phospholipid clearance.
• PPARγ-agonist therapy enhanced macrophage cholesterol clearance and ameliorated PAP in mice.

Conclusions:

• GM-CSF is indispensable for effective cholesterol clearance by macrophages.
• Impaired macrophage cholesterol clearance is a key pathogenic mechanism in PAP.
• Pioglitazone (a PPARγ-agonist) represents a potential novel therapeutic strategy for PAP.